Science News & Science Current Events
 

Therapeutic Cloning Current Events | Therapeutic Cloning News | 3
Page 3 of 14 | 328 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
In Search Of Genetic Precision (p 357)
This week's Lancet editorial calls into question the current way in which studies that suggest an association between a gene and a particular disease are published, and discusses the criticism that scientific journals-including THE LANCET-have received when they report these studies. The main... view more (2003-01-29)

Omega-3 supplements affect Alzheimer's symptoms
Omega-3 supplements can, in certain cases, help combat the depression and agitation symptoms associated with Alzheimer's disease, according to a clinical study conducted at the Swedish medical university Karolinska Institutet.   view more (2007-06-21)

WHAT FUTURE FOR CANNABIS?
The potential therapeutic effects of cannabis are outlined in a review in the May issue of THE LANCET NEUROLOGY. The review is published in anticipation of results from randomised trials expected later this year investigating possible benefits of the drug for people with multiple sclerosis. The... view more (2003-04-16)

Xerion Pharmaceuticals Enters Into Option Agreement For Cancer Targets From Tufts University
Martinsried, Germany and Cambridge, MA, February 26, 2003 - Xerion Pharmaceuticals announced today that it has acquired exclusive rights to cancer targets resulting from the collaboration between Xerion and the laboratory of Daniel G. Jay, Ph.D., Professor of Physiology at Tufts University. Xerion... view more (2003-02-26)

Science & Public Affairs - August 2000
In this month’s Science & Public Affairs….. animal research: the public’s view and need for regulatory change; where will the human genome project take us?; the need for urgent action on the nuclear waste problem; promoting science communication in the developing world; the... view more (2000-08-03)

Dr David Shannon unhappy with scientists` advising of the government on foot and mouth - In February`s Science & Public Affairs
Main story in this month’s Science & Public Affairs: DEFRA’s newly retired chief scientist Dr David Shannon says he is unhappy with the way scientists advised government on foot and mouth. “The committee which advised the Government’s Chief Scientist, Professor David... view more (2002-02-18)

POLYMUN Scientific to present at the 4X4 pour entrepreneur
POLYMUN Scientific, together with 20 other companies, has been selected from 300 submissions to present its innovative pharmaceutical projects at the prestigious "Taste of Entrepreneurship: Financing and Research" symposium in Louvain-La-Neuve, Belgium, Nov. 19 and 20, 2002. POLYMUN will present... view more (2002-11-15)

Can Antidepressant Drugs Prevent Recurrence Of Depression? The News Is Depressiong.
Prolonging antidepressant drug treatment to prevent recurrence of depression does not appear to be an optimal solution for many patients concludes a review of Giovanni A Fava, Chiara Ruini (University of Bologna) and Nicoletta Sonino (University of Padova). The chronic and recurrent nature of major... view more (2004-02-16)

Lords Call For Faster Progress Towards Cannabis-Based Medicine
Progress towards a cannabis-based medicine for conditions such as multiple sclerosis is too slow, says the House of Lords Science & Technology Committee in a report published today [22 March]. The use of cannabis for any purpose other than scientific research is currently illegal. In November... view more (2001-03-22)

Young People Review Science Curriculum
As part of Science Year, nearly 2000 students, aged 16-19, have developed and taken part in a survey of the science curriculum, whose initial findings are released today. A majority (68%) of students polled in the UK`s first online students` survey, which was conducted through the Science Year and... view more (2002-03-19)

When Depression Comes Back: What To Do Is Not What "Big PHRMA" Wants You To Do.
Relapse is a major problem for depressed patients. With this review, Psychotherapy and Psychosomatics launches a new section (case Management), which addresses management of cases in clinical practice. Investigators with conflict of interest are excluded from contributing. The Authors are from the... view more (2003-01-13)

Researchers Can Cross Non-Interbreeding Plants
Researchers of the All-Russian Scientific Research Institute of Plant Cultivation, Russian Academy of Agricultural Sciences (St. Petersburg) jointly with their colleagues from Germany and Finland have grown up new lines of Solanum cultivated plants via the somatic hybridization method - hybrids of... view more (2004-11-05)

Dartmouth, GlycoFi researchers make leap in protein bioengineering
Investigators at Dartmouth's Thayer School of Engineering, the Dartmouth-Hitchcock Medical Center, and the biotechnology firm GlycoFi, Inc., report a breakthrough in using yeast to produce antibodies with human sugar structures.   view more (2006-01-23)

Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents. Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body.   view more (2007-05-21)

Xerion Pharmaceuticals and Arius Research sign colon cancer collaboration
Martinsried, Germany and Cambridge, Massachusetts, USA - October 15, 2002"¦Xerion Pharmaceuticals and ARIUS Research Inc. of Canada announced today that they would combine their respective strengths in functional proteomics and antibody discovery to jointly develop products for cancer therapy.... view more (2002-10-15)

Neurotherapeutics presents special issue on new treatments for Alzheimer's disease
The editors of Neurotherapeutics are pleased and proud to announce their July issue, devoted to "Novel Therapeutics for Alzheimer's Disease."   view more (2008-07-25)

New technology makes clinical research more precise
The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans.   view more (2006-12-12)

Protein's potential as a regulator of brain activity discovered
UC Irvine researchers have found that a protein best known for building connections between nerve cells and muscle also plays a role in controlling brain cell activity.   view more (2006-04-21)

New journal for the 21st century drug hunter launched
Drug discovery researchers will be able to keep up-to-date with the latest developments in therapeutic drug discovery with a new peer-reviewed journal, Current Opinion in Investigational Drugs, launched today (25 September) by PharmaPress Ltd. This monthly journal aims to provide a comprehensive... view more (2000-09-20)

Making the case for science
Do current controversies over GMOs and cloning indicate that the views of the science community are not having an impact on opinions in parliament, government, industry, the media and the public? How should the scientific community meet the needs of the public for scientific information? Is the... view more (1999-03-31)

Limitations of Current Evaluation Techniques for the Cost-Effectiveness of Treatments for Parkinson's Disease
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Pharmaceutical and surgical therapies for PD are available and can alleviate the symptoms and complications. Unfortunately, despite these therapies, the disease relentlessly progresses. A new study in the journal Value... view more (2004-11-10)

Previous claims of siRNA therapeutic effects called into question by report in human gene therapy
The many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be describing non-specific therapeutic effects related to the ability of siRNA to activate an immune response, according to a paper in the September 2008... view more (2008-09-03)

Genetic Marker for Asthma Identified at Oxford
Researchers at Oxford University's Wellcome Trust Centre for Human Genetics have located a variant form of a polynucleotide sequence in the MHC region of chromosome 6p and identified its association with an increased secretion of TNF. Potential applications for this discovery include the diagnosis... view more (2003-02-10)

Genetic analysis enables personalising of treatment of cancer of the lung and colon and of certain sarcomas
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity.   view more (2007-03-06)

The social care function of farm animals
Farm animals can play a valuable role in the lives of children and adults with psychological problems or a mental handicap. Social care farms and children's farms can improve the quality of their life, as shown by interviews with counsellors and managers of children's farms and social care farmers.... view more (2002-04-22)
Page 3 of 14 | 328 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com